Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2025-12-24 @ 12:46 PM
NCT ID:
NCT02562261
Eligibility Criteria:
Inclusion Criteria:
* Patients presenting 0-8 hours post admission with signs of one of the following i) uncomplicated infection/bacteremia ii) sepsis iii) severe sepsis iv) septic shock
* 30 healthy subjects
* Signed informed consent
Exclusion Criteria:
* Pregnancy
* Breastfeeding
* Inability to give informed consent
* PLTs\<70.000/ul or PLTs\>741.000 ul
* Ht\<25% or Ht\>52%
* History of P2Y12 or GPIIb/IIIainhibitors the last 15 days prior assortment
* Patients with inherited (vonWillebrand factor deficiency, Glanzmann thrombasthenia, Bernard-Sulier syndrome) or established acquired platelet disorders (HIT)
* Patients undergoing hemodialysis
* History of gastrointestinal bleeding, genitourinary bleeding or other site abnormal bleeding within the previous 3 months.
* Previous history of immunologic disease (neoplasm, autoimmune disorders, HIV)
* Subjects receiving daily treatment with immune-modulating regimens.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02562261
Study Brief:
Protocol Section:
NCT02562261